Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), Enduser (Hospital, Diagnostic & Research Labs) - Global Forecast to 2025
The global albumin & creatinine tests market size is valued at an estimated USD 987 million in 2020 and is projected to reach USD 2,103 million by 2025, at a CAGR of 16.3% during the forecast period. The growth of the global albumin & creatinine tests market is driven by factors such as growing prevalence of kidney disorders, the rising adoption of POC diagnostics, and the increasing prevalence of chronic conditions. However, factors like unfavorable healthcare reforms in the US and the high cost of automated analyzers are hampering the growth of the albumin & creatinine tests market during the forecasted period.
“The dipstick & kits segment accounted for the highest growth rate in the albumin & creatinine tests market, by product, during the forecast period “
Based on product, the albumin & creatinine tests market is segmented into dipsticks & kits, analyzers, cartridges, and reagents & other consumables. In 2019, the dipsticks & kits segment accounted for the largest share in this market. The frequent purchase of these products compared to instruments like analyzers and cartridges and the increasing use of kit-based rapid techniques for albumin & creatinine tests drive market growth.
“Urine Tests segment accounted for the highest CAGR”
Based on type, the albumin & creatinine tests market is segmented into urine tests and blood & serum creatinine tests. In 2019, urine tests accounted for the largest share in this market. Factors such as the rapid growth in the diagnostics segment and the increasing demand for rapid and easy-to-use urine tests drive the growth of this segment.
“Asia Pacific: The fastest-growing region albumin & creatinine tests market”
The Asia Pacific albumin & creatinine tests market is estimated to grow at the highest CAGR, mainly due to the expansion of key market players in emerging Asian countries, increasing expenditure on life science and medical research in the region, and the increasing geriatric population and prevalence of chronic conditions in Asian countries such as India and China.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the global albumin & creatinine tests market. It aims at estimating the size and future growth potential of the market across different segments, such as product, technique, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall albumin & creatinine tests market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, challenges, and trends.
“The dipstick & kits segment accounted for the highest growth rate in the albumin & creatinine tests market, by product, during the forecast period “
Based on product, the albumin & creatinine tests market is segmented into dipsticks & kits, analyzers, cartridges, and reagents & other consumables. In 2019, the dipsticks & kits segment accounted for the largest share in this market. The frequent purchase of these products compared to instruments like analyzers and cartridges and the increasing use of kit-based rapid techniques for albumin & creatinine tests drive market growth.
“Urine Tests segment accounted for the highest CAGR”
Based on type, the albumin & creatinine tests market is segmented into urine tests and blood & serum creatinine tests. In 2019, urine tests accounted for the largest share in this market. Factors such as the rapid growth in the diagnostics segment and the increasing demand for rapid and easy-to-use urine tests drive the growth of this segment.
“Asia Pacific: The fastest-growing region albumin & creatinine tests market”
The Asia Pacific albumin & creatinine tests market is estimated to grow at the highest CAGR, mainly due to the expansion of key market players in emerging Asian countries, increasing expenditure on life science and medical research in the region, and the increasing geriatric population and prevalence of chronic conditions in Asian countries such as India and China.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35%
- By Designation: C-level - 30%, D-level - 20%, and Others - 50%
- By Region: North America - 36%, Europe - 25%, Asia Pacific - 27%, Latin America – 9%, and Middle East and Africa – 3%.
- Thermo Fisher Scientific, Inc. (US)
- Roche Diagnostics (Switzerland)
- PromoCell GmbH (Germany)
- Abbott Laboratories (US)
- Siemens Healthineers (Germany)
- Danaher Corporation (US)
- Sysmex Corporation (Japan)
- Ortho Clinical Diagnostics (US)
- Randox Laboratories (UK)
- FUJIFILM Wako Pure Chemical Corporation (Japan)
- Abbexa Ltd. (UK)
- ACON Laboratories, Inc. (US)
- Arbor Assays Inc. (US)
- ARKRAY Global Business Inc. (Japan)
- Aviva Systems Biology (US)
- Axxora, LLC (UK)
- BioAssay Systems (US)
- Nova Biomedical (US)
- Quantimetrix Corporation (US)
- RayBiotech Inc. (US)
- Sekisui Diagnostics PEI Inc. (US)
- Teco Diagnostics (US)
- Tulip Diagnostics (India)
- ulti med Products GmbH (Germany)
- URIT Medical Electronic Co., Ltd. (China)
This report provides a detailed picture of the global albumin & creatinine tests market. It aims at estimating the size and future growth potential of the market across different segments, such as product, technique, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall albumin & creatinine tests market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, challenges, and trends.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
FIGURE 1 INCLUSIONS & EXCLUSIONS
1.2.1 MARKETS COVERED
FIGURE 2 ALBUMIN & CREATININE TESTS MARKET SEGMENTATION
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 5 ALBUMIN & CREATININE TESTS MARKET: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 6 ALBUMIN & CREATININE TESTS MARKET: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 8 ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 9 ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 10 ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 11 ALBUMIN & CREATININE TESTS MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 ALBUMIN & CREATININE TESTS MARKET OVERVIEW
FIGURE 12 RISING ADOPTION OF POC PRODUCTS TO DRIVE MARKET GROWTH
4.2 ALBUMIN & CREATININE TESTS MARKET, BY CARTRIDGE TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 13 POC ANALYZER CARTRIDGES SEGMENT TO COMMAND THE LARGEST MARKET SHARE IN 2019
4.3 URINE TESTS MARKET, BY TYPE, 2020 VS. 2025
FIGURE 14 URINE ALBUMIN TESTS TO HOLD THE LARGEST MARKET SHARE
4.4 ALBUMIN & CREATININE TESTS MARKET, BY REGION, 2020 VS. 2025
FIGURE 15 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 ALBUMIN & CREATININE TESTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of kidney disorders
5.2.1.2 Increasing adoption of point-of-care (POC) diagnostics
5.2.1.3 Growing global prevalence of chronic conditions leading
to kidney diseases
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable healthcare reforms in the US
5.2.3 OPPORTUNITIES
5.2.3.1 Integrated and automated systems for overall urine analysis
5.2.3.2 Emerging economies to provide significant opportunities
5.2.4 CHALLENGES
5.2.4.1 High cost of automated analyzers
5.2.4.2 High degree of consolidation acts as an entry barrier for new entrants
5.3 IMPACT OF COVID-19 ON THE ALBUMIN & CREATININE TESTS MARKET
5.4 ECOSYSTEM ANALYSIS
5.5 VALUE CHAIN ANALYSIS
FIGURE 17 VALUE CHAIN ANALYSIS OF THE ALBUMIN & CREATININE TESTS MARKET
FIGURE 18 RESTRAINTS IN THE VALUE CHAIN FOR POC DIAGNOSTICS, BY STAGE
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 19 SUPPLY CHAIN ANALYSIS OF THE ALBUMIN & CREATININE TESTS MARKET
5.7 PESTLE ANALYSIS
FIGURE 20 PESTLE ANALYSIS OF THE ALBUMIN & CREATININE TESTS MARKET
6 ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 1 AVERAGE SELLING PRICES OF PRODUCTS (USD)
TABLE 2 ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
6.2 DIPSTICKS & KITS
6.2.1 COST-EFFECTIVENESS AND EASE OF USE TO DRIVE MARKET GROWTH
TABLE 3 DIPSTICKS & KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3 ANALYZERS
6.3.1 ADOPTION OF POC ANALYZERS HAS INCREASED IN RECENT YEARS
TABLE 4 ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4 CARTRIDGES
TABLE 5 CARTRIDGES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 6 CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
6.4.1 POC ANALYZER CARTRIDGES
6.4.1.1 Increasing adoption of POC technologies to drive market growth
TABLE 7 POC ANALYZER CARTRIDGES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4.2 TABLE-TOP ANALYZER CARTRIDGES
6.4.2.1 Table-top analyzers and cartridges are used in hospitals, labs, and research
TABLE 8 TABLE-TOP ANALYZER CARTRIDGES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.5 REAGENTS & OTHER CONSUMABLES
6.5.1 INCREASING USE OF CONTROLS AND CALIBRATORS TO DRIVE MARKET GROWTH
TABLE 9 REAGENTS & OTHER CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
7 ALBUMIN & CREATININE TESTS MARKET, BY TYPE
7.1 INTRODUCTION
TABLE 10 ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
7.2 URINE TESTS
TABLE 11 URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 12 URINE TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.1 URINE ALBUMIN TESTS
7.2.1.1 Increasing prevalence of hypertension to drive market growth
TABLE 13 URINE ALBUMIN TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2 URINE CREATININE TESTS
7.2.2.1 Increasing prevalence of drug nephrotoxicity to drive market growth
TABLE 14 URINE CREATININE TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.3 GLYCATED ALBUMIN TESTS
7.2.3.1 Increasing prevalence of diabetes to drive market growth
TABLE 15 GLYCATED ALBUMIN TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3 BLOOD & SERUM CREATININE TESTS
7.3.1 INCREASING PREVALENCE OF CHRONIC CONDITIONS TO DRIVE MARKET GROWTH
TABLE 16 BLOOD & SERUM CREATININE TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
8 ALBUMIN & CREATININE TESTS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 17 ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
8.2 HOSPITALS & CLINICS
8.2.1 RISING NUMBER OF HOSPITALS TO DRIVE MARKET GROWTH
TABLE 18 ALBUMIN & CREATININE TESTS MARKET FOR HOSPITALS & CLINICS,
BY REGION, 2018–2025 (USD MILLION)
8.3 DIAGNOSTIC LABORATORIES
8.3.1 INCREASING OUTSOURCING BY HOSPITALS IS SUPPORTING THE GROWTH OF THIS END-USER SEGMENT
TABLE 19 ALBUMIN & CREATININE TESTS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2018–2025 (USD MILLION)
8.4 RESEARCH LABORATORIES & INSTITUTES
8.4.1 INCREASING INVESTMENTS IN RESEARCH IS THE MAJOR FACTOR CONTRIBUTING TO MARKET GROWTH
TABLE 20 ALBUMIN & CREATININE TESTS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
9 ALBUMIN & CREATININE TESTS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 21 ALBUMIN & CREATININE TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: ALBUMIN & CREATININE TESTS MARKET SNAPSHOT
TABLE 22 NORTH AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 NORTH AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 24 NORTH AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 25 NORTH AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2.1 US
9.2.1.1 Increasing geriatric population to drive market growth in the US
TABLE 26 US: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 27 US: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 28 US: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 29 US: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 30 US: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising prevalence of diabetes to drive market growth
TABLE 31 CANADA: INCIDENCE OF DIABETES, 2019 VS. 2029
TABLE 32 CANADA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 33 CANADA: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 34 CANADA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 35 CANADA: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 36 CANADA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3 EUROPE
TABLE 37 EUROPE: PREVALENCE OF DIABETES (20–79 YEARS), 2019 VS. 2045
TABLE 38 EUROPE: ALBUMIN & CREATININE TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 39 EUROPE: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 40 EUROPE: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 41 EUROPE: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.1 UK
9.3.1.1 Rising incidence of chronic kidney disorders to drive market growth
TABLE 42 UK: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 43 UK: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 44 UK: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 45 UK: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 46 UK: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Increasing healthcare expenditure to drive market growth
TABLE 47 GERMANY: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 48 GERMANY: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 49 GERMANY: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 50 GERMANY: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 51 GERMANY: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Rising R&D expenditure to drive market growth
TABLE 52 FRANCE: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 53 FRANCE: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 54 FRANCE: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 55 FRANCE: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 56 FRANCE: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Large geriatric population to drive the growth of the albumin & creatinine tests market in Italy
TABLE 57 ITALY: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 58 ITALY: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 59 ITALY: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 60 ITALY: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 ITALY: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising prevalence of CKD in Spain to drive market growth
TABLE 62 SPAIN: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 63 SPAIN: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 64 SPAIN: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 SPAIN: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 66 SPAIN: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.6 RUSSIA
9.3.6.1 Government focus on increasing diabetes awareness will favor market growth in Russia
TABLE 67 RUSSIA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 68 RUSSIA: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 RUSSIA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 70 RUSSIA: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 71 RUSSIA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 72 ROE: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 73 ROE: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 74 ROE: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 75 ROE: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 76 ROE: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 22 APAC: ALBUMIN & CREATININE TESTS MARKET SNAPSHOT
TABLE 77 APAC: ALBUMIN & CREATININE TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 78 APAC: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 79 APAC: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 80 APAC: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China accounts for the largest share of the APAC market
TABLE 81 CHINA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 82 CHINA: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 83 CHINA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 84 CHINA: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85 CHINA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Favorable regulatory framework to drive market growth
TABLE 86 JAPAN: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 87 JAPAN: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 88 JAPAN: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 89 JAPAN: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 JAPAN: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.3 AUSTRALIA
9.4.3.1 Increasing incidence of diabetes is driving market growth
TABLE 91 AUSTRALIA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 92 AUSTRALIA: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 93 AUSTRALIA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 94 AUSTRALIA: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 95 AUSTRALIA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.4 SOUTH KOREA
9.4.4.1 Rising geriatric population to drive market growth
TABLE 96 SOUTH KOREA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 97 SOUTH KOREA: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 SOUTH KOREA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 SOUTH KOREA: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 100 SOUTH KOREA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 101 ROAPAC: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 102 ROAPAC: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 ROAPAC: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 104 ROAPAC: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 105 ROAPAC: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.5 LATIN AMERICA
TABLE 106 LATIN AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 107 LATIN AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 108 LATIN AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 109 LATIN AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 High prevalence of chronic conditions to promote market growth
TABLE 110 BRAZIL: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 111 BRAZIL: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 112 BRAZIL: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 113 BRAZIL: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 114 BRAZIL: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Rising prevalence of diabetes to drive market growth in Mexico
TABLE 115 MEXICO: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 116 MEXICO: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 MEXICO: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 118 MEXICO: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 119 MEXICO: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 120 ROLATAM: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 121 ROLATAM: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 ROLATAM: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 ROLATAM: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 124 ROLATAM: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
9.6.1 INCREASING HEALTHCARE EXPENDITURE TO DRIVE MARKET GROWTH IN THE MIDDLE EAST AND AFRICA
TABLE 125 MEA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 126 MEA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 127 MEA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
FIGURE 23 KEY DEVELOPMENTS IN THE ALBUMIN & CREATININE TESTS MARKET (JANUARY 2017–NOVEMBER 2020)
10.2 ALBUMIN & CREATININE TESTS MARKET SHARE ANALYSIS
FIGURE 24 ALBUMIN & CREATININE TESTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
10.3 COMPANY EVALUATION QUADRANT
10.3.1 DEFINITION AND METHODOLOGY
10.3.2 VENDOR DIVE OVERVIEW
10.3.2.1 Stars
10.3.2.2 Emerging leaders
10.3.2.3 Pervasive
10.3.2.4 Participants
FIGURE 25 ALBUMIN & CREATININE TESTS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
10.4 COMPANY EVALUATION MATRIX FOR START-UPS (2019)
10.4.1 PROGRESSIVE COMPANIES
10.4.2 RESPONSIVE COMPANIES
10.4.3 STARTING BLOCKS
10.4.4 DYNAMIC COMPANIES
FIGURE 26 ALBUMIN & CREATININE TESTS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS, 2019
10.5 COMPETITIVE SCENARIO
10.5.1 PRODUCT LAUNCHES & REGULATORY APPROVALS
TABLE 128 PRODUCT LAUNCHES & REGULATORY APPROVALS (JANUARY 2017–NOVEMBER 2020)
10.5.2 PARTNERSHIPS & AGREEMENTS
TABLE 129 PARTNERSHIPS & AGREEMENTS (JANUARY 2017–NOVEMBER 2020)
10.5.3 ACQUISITIONS
TABLE 130 ACQUISITIONS (JANUARY 2017–NOVEMBER 2020)
10.5.4 EXPANSIONS
TABLE 131 EXPANSIONS (JANUARY 2017–NOVEMBER 2020)
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1.1 ABBOTT LABORATORIES
FIGURE 27 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
11.1.2 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMAN-LA ROCHE AG)
FIGURE 28 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2019)
11.1.3 SIEMENS HEALTHINEERS AG
FIGURE 29 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019)
11.1.4 DANAHER CORPORATION
FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
11.1.5 THERMO FISHER SCIENTIFIC, INC.
FIGURE 31 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
11.1.6 SYSMEX CORPORATION
FIGURE 32 SYSMEX CORPORATION: COMPANY SNAPSHOT (2019)
11.1.7 ORTHO CLINICAL DIAGNOSTICS
11.1.8 PROMOCELL GMBH
11.1.9 RANDOX LABORATORIES
11.1.10 FUJIFILM WAKO PURE CHEMICAL CORPORATION
11.2 OTHER PLAYERS
11.2.1 ABBEXA LTD.
11.2.2 ACON LABORATORIES, INC.
11.2.3 ARBOR ASSAYS, INC.
11.2.4 ARKRAY GLOBAL BUSINESS, INC.
11.2.5 AVIVA SYSTEMS BIOLOGY
11.2.6 AXXORA, LLC
11.2.7 BIOASSAY SYSTEMS
11.2.8 NOVA BIOMEDICAL CORPORATION
11.2.9 QUANTIMETRIX CORPORATION
11.2.10 RAYBIOTECH, INC.
11.2.11 SEKISUI DIAGNOSTICS PEI INC.
11.2.12 TECO DIAGNOSTICS
11.2.13 TULIP DIAGNOSTICS LTD.
11.2.14 ULTI MED PRODUCTS GMBH
11.2.15 URIT MEDICAL ELECTRONIC CO., LTD.
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
FIGURE 1 INCLUSIONS & EXCLUSIONS
1.2.1 MARKETS COVERED
FIGURE 2 ALBUMIN & CREATININE TESTS MARKET SEGMENTATION
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 5 ALBUMIN & CREATININE TESTS MARKET: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 6 ALBUMIN & CREATININE TESTS MARKET: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 8 ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 9 ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 10 ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 11 ALBUMIN & CREATININE TESTS MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 ALBUMIN & CREATININE TESTS MARKET OVERVIEW
FIGURE 12 RISING ADOPTION OF POC PRODUCTS TO DRIVE MARKET GROWTH
4.2 ALBUMIN & CREATININE TESTS MARKET, BY CARTRIDGE TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 13 POC ANALYZER CARTRIDGES SEGMENT TO COMMAND THE LARGEST MARKET SHARE IN 2019
4.3 URINE TESTS MARKET, BY TYPE, 2020 VS. 2025
FIGURE 14 URINE ALBUMIN TESTS TO HOLD THE LARGEST MARKET SHARE
4.4 ALBUMIN & CREATININE TESTS MARKET, BY REGION, 2020 VS. 2025
FIGURE 15 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 ALBUMIN & CREATININE TESTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of kidney disorders
5.2.1.2 Increasing adoption of point-of-care (POC) diagnostics
5.2.1.3 Growing global prevalence of chronic conditions leading
to kidney diseases
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable healthcare reforms in the US
5.2.3 OPPORTUNITIES
5.2.3.1 Integrated and automated systems for overall urine analysis
5.2.3.2 Emerging economies to provide significant opportunities
5.2.4 CHALLENGES
5.2.4.1 High cost of automated analyzers
5.2.4.2 High degree of consolidation acts as an entry barrier for new entrants
5.3 IMPACT OF COVID-19 ON THE ALBUMIN & CREATININE TESTS MARKET
5.4 ECOSYSTEM ANALYSIS
5.5 VALUE CHAIN ANALYSIS
FIGURE 17 VALUE CHAIN ANALYSIS OF THE ALBUMIN & CREATININE TESTS MARKET
FIGURE 18 RESTRAINTS IN THE VALUE CHAIN FOR POC DIAGNOSTICS, BY STAGE
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 19 SUPPLY CHAIN ANALYSIS OF THE ALBUMIN & CREATININE TESTS MARKET
5.7 PESTLE ANALYSIS
FIGURE 20 PESTLE ANALYSIS OF THE ALBUMIN & CREATININE TESTS MARKET
6 ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 1 AVERAGE SELLING PRICES OF PRODUCTS (USD)
TABLE 2 ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
6.2 DIPSTICKS & KITS
6.2.1 COST-EFFECTIVENESS AND EASE OF USE TO DRIVE MARKET GROWTH
TABLE 3 DIPSTICKS & KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3 ANALYZERS
6.3.1 ADOPTION OF POC ANALYZERS HAS INCREASED IN RECENT YEARS
TABLE 4 ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4 CARTRIDGES
TABLE 5 CARTRIDGES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 6 CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
6.4.1 POC ANALYZER CARTRIDGES
6.4.1.1 Increasing adoption of POC technologies to drive market growth
TABLE 7 POC ANALYZER CARTRIDGES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4.2 TABLE-TOP ANALYZER CARTRIDGES
6.4.2.1 Table-top analyzers and cartridges are used in hospitals, labs, and research
TABLE 8 TABLE-TOP ANALYZER CARTRIDGES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.5 REAGENTS & OTHER CONSUMABLES
6.5.1 INCREASING USE OF CONTROLS AND CALIBRATORS TO DRIVE MARKET GROWTH
TABLE 9 REAGENTS & OTHER CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
7 ALBUMIN & CREATININE TESTS MARKET, BY TYPE
7.1 INTRODUCTION
TABLE 10 ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
7.2 URINE TESTS
TABLE 11 URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 12 URINE TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.1 URINE ALBUMIN TESTS
7.2.1.1 Increasing prevalence of hypertension to drive market growth
TABLE 13 URINE ALBUMIN TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2 URINE CREATININE TESTS
7.2.2.1 Increasing prevalence of drug nephrotoxicity to drive market growth
TABLE 14 URINE CREATININE TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.3 GLYCATED ALBUMIN TESTS
7.2.3.1 Increasing prevalence of diabetes to drive market growth
TABLE 15 GLYCATED ALBUMIN TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3 BLOOD & SERUM CREATININE TESTS
7.3.1 INCREASING PREVALENCE OF CHRONIC CONDITIONS TO DRIVE MARKET GROWTH
TABLE 16 BLOOD & SERUM CREATININE TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
8 ALBUMIN & CREATININE TESTS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 17 ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
8.2 HOSPITALS & CLINICS
8.2.1 RISING NUMBER OF HOSPITALS TO DRIVE MARKET GROWTH
TABLE 18 ALBUMIN & CREATININE TESTS MARKET FOR HOSPITALS & CLINICS,
BY REGION, 2018–2025 (USD MILLION)
8.3 DIAGNOSTIC LABORATORIES
8.3.1 INCREASING OUTSOURCING BY HOSPITALS IS SUPPORTING THE GROWTH OF THIS END-USER SEGMENT
TABLE 19 ALBUMIN & CREATININE TESTS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2018–2025 (USD MILLION)
8.4 RESEARCH LABORATORIES & INSTITUTES
8.4.1 INCREASING INVESTMENTS IN RESEARCH IS THE MAJOR FACTOR CONTRIBUTING TO MARKET GROWTH
TABLE 20 ALBUMIN & CREATININE TESTS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
9 ALBUMIN & CREATININE TESTS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 21 ALBUMIN & CREATININE TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: ALBUMIN & CREATININE TESTS MARKET SNAPSHOT
TABLE 22 NORTH AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 NORTH AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 24 NORTH AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 25 NORTH AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2.1 US
9.2.1.1 Increasing geriatric population to drive market growth in the US
TABLE 26 US: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 27 US: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 28 US: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 29 US: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 30 US: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising prevalence of diabetes to drive market growth
TABLE 31 CANADA: INCIDENCE OF DIABETES, 2019 VS. 2029
TABLE 32 CANADA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 33 CANADA: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 34 CANADA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 35 CANADA: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 36 CANADA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3 EUROPE
TABLE 37 EUROPE: PREVALENCE OF DIABETES (20–79 YEARS), 2019 VS. 2045
TABLE 38 EUROPE: ALBUMIN & CREATININE TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 39 EUROPE: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 40 EUROPE: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 41 EUROPE: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.1 UK
9.3.1.1 Rising incidence of chronic kidney disorders to drive market growth
TABLE 42 UK: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 43 UK: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 44 UK: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 45 UK: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 46 UK: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Increasing healthcare expenditure to drive market growth
TABLE 47 GERMANY: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 48 GERMANY: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 49 GERMANY: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 50 GERMANY: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 51 GERMANY: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Rising R&D expenditure to drive market growth
TABLE 52 FRANCE: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 53 FRANCE: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 54 FRANCE: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 55 FRANCE: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 56 FRANCE: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Large geriatric population to drive the growth of the albumin & creatinine tests market in Italy
TABLE 57 ITALY: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 58 ITALY: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 59 ITALY: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 60 ITALY: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 ITALY: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising prevalence of CKD in Spain to drive market growth
TABLE 62 SPAIN: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 63 SPAIN: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 64 SPAIN: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 SPAIN: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 66 SPAIN: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.6 RUSSIA
9.3.6.1 Government focus on increasing diabetes awareness will favor market growth in Russia
TABLE 67 RUSSIA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 68 RUSSIA: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 RUSSIA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 70 RUSSIA: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 71 RUSSIA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 72 ROE: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 73 ROE: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 74 ROE: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 75 ROE: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 76 ROE: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 22 APAC: ALBUMIN & CREATININE TESTS MARKET SNAPSHOT
TABLE 77 APAC: ALBUMIN & CREATININE TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 78 APAC: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 79 APAC: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 80 APAC: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China accounts for the largest share of the APAC market
TABLE 81 CHINA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 82 CHINA: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 83 CHINA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 84 CHINA: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85 CHINA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Favorable regulatory framework to drive market growth
TABLE 86 JAPAN: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 87 JAPAN: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 88 JAPAN: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 89 JAPAN: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 JAPAN: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.3 AUSTRALIA
9.4.3.1 Increasing incidence of diabetes is driving market growth
TABLE 91 AUSTRALIA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 92 AUSTRALIA: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 93 AUSTRALIA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 94 AUSTRALIA: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 95 AUSTRALIA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.4 SOUTH KOREA
9.4.4.1 Rising geriatric population to drive market growth
TABLE 96 SOUTH KOREA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 97 SOUTH KOREA: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 SOUTH KOREA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 SOUTH KOREA: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 100 SOUTH KOREA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 101 ROAPAC: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 102 ROAPAC: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 ROAPAC: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 104 ROAPAC: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 105 ROAPAC: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.5 LATIN AMERICA
TABLE 106 LATIN AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 107 LATIN AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 108 LATIN AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 109 LATIN AMERICA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 High prevalence of chronic conditions to promote market growth
TABLE 110 BRAZIL: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 111 BRAZIL: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 112 BRAZIL: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 113 BRAZIL: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 114 BRAZIL: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Rising prevalence of diabetes to drive market growth in Mexico
TABLE 115 MEXICO: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 116 MEXICO: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 MEXICO: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 118 MEXICO: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 119 MEXICO: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 120 ROLATAM: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 121 ROLATAM: ALBUMIN & CREATININE TEST CARTRIDGES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 ROLATAM: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 ROLATAM: URINE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 124 ROLATAM: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
9.6.1 INCREASING HEALTHCARE EXPENDITURE TO DRIVE MARKET GROWTH IN THE MIDDLE EAST AND AFRICA
TABLE 125 MEA: ALBUMIN & CREATININE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 126 MEA: ALBUMIN & CREATININE TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 127 MEA: ALBUMIN & CREATININE TESTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
FIGURE 23 KEY DEVELOPMENTS IN THE ALBUMIN & CREATININE TESTS MARKET (JANUARY 2017–NOVEMBER 2020)
10.2 ALBUMIN & CREATININE TESTS MARKET SHARE ANALYSIS
FIGURE 24 ALBUMIN & CREATININE TESTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
10.3 COMPANY EVALUATION QUADRANT
10.3.1 DEFINITION AND METHODOLOGY
10.3.2 VENDOR DIVE OVERVIEW
10.3.2.1 Stars
10.3.2.2 Emerging leaders
10.3.2.3 Pervasive
10.3.2.4 Participants
FIGURE 25 ALBUMIN & CREATININE TESTS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
10.4 COMPANY EVALUATION MATRIX FOR START-UPS (2019)
10.4.1 PROGRESSIVE COMPANIES
10.4.2 RESPONSIVE COMPANIES
10.4.3 STARTING BLOCKS
10.4.4 DYNAMIC COMPANIES
FIGURE 26 ALBUMIN & CREATININE TESTS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS, 2019
10.5 COMPETITIVE SCENARIO
10.5.1 PRODUCT LAUNCHES & REGULATORY APPROVALS
TABLE 128 PRODUCT LAUNCHES & REGULATORY APPROVALS (JANUARY 2017–NOVEMBER 2020)
10.5.2 PARTNERSHIPS & AGREEMENTS
TABLE 129 PARTNERSHIPS & AGREEMENTS (JANUARY 2017–NOVEMBER 2020)
10.5.3 ACQUISITIONS
TABLE 130 ACQUISITIONS (JANUARY 2017–NOVEMBER 2020)
10.5.4 EXPANSIONS
TABLE 131 EXPANSIONS (JANUARY 2017–NOVEMBER 2020)
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1.1 ABBOTT LABORATORIES
FIGURE 27 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
11.1.2 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMAN-LA ROCHE AG)
FIGURE 28 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2019)
11.1.3 SIEMENS HEALTHINEERS AG
FIGURE 29 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019)
11.1.4 DANAHER CORPORATION
FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
11.1.5 THERMO FISHER SCIENTIFIC, INC.
FIGURE 31 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
11.1.6 SYSMEX CORPORATION
FIGURE 32 SYSMEX CORPORATION: COMPANY SNAPSHOT (2019)
11.1.7 ORTHO CLINICAL DIAGNOSTICS
11.1.8 PROMOCELL GMBH
11.1.9 RANDOX LABORATORIES
11.1.10 FUJIFILM WAKO PURE CHEMICAL CORPORATION
11.2 OTHER PLAYERS
11.2.1 ABBEXA LTD.
11.2.2 ACON LABORATORIES, INC.
11.2.3 ARBOR ASSAYS, INC.
11.2.4 ARKRAY GLOBAL BUSINESS, INC.
11.2.5 AVIVA SYSTEMS BIOLOGY
11.2.6 AXXORA, LLC
11.2.7 BIOASSAY SYSTEMS
11.2.8 NOVA BIOMEDICAL CORPORATION
11.2.9 QUANTIMETRIX CORPORATION
11.2.10 RAYBIOTECH, INC.
11.2.11 SEKISUI DIAGNOSTICS PEI INC.
11.2.12 TECO DIAGNOSTICS
11.2.13 TULIP DIAGNOSTICS LTD.
11.2.14 ULTI MED PRODUCTS GMBH
11.2.15 URIT MEDICAL ELECTRONIC CO., LTD.
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
